Loading...
OTCM
BIEI
Market cap599kUSD
Dec 05, Last price  
0.00USD
1D
-14.29%
1Q
-45.45%
Jan 2017
-88.00%
IPO
-99.94%
Name

Premier Biomedical Inc

Chart & Performance

D1W1MN
OTCM:BIEI chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
83.79%
Rev. gr., 5y
-37.00%
Revenues
0k
00000039,76139,79514,28100000
Net income
-99k
L-51.11%
-111,862-1,714,023-4,877,148-1,410,514-2,582,171-1,768,221-3,763,558-398,886-374,470-403,167-38,772-49,260-202,173-98,841
CFO
-171k
L
-94,021-126,594-428,190-639,077-462,225-483,622-509,432-444,878-344,180-71,197-5,0002,934-170,993

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
IPO date
Feb 23, 2012
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT